Our News on Newswise

Association for Molecular Pathology Releases Preliminary Results to Nationwide SARS-CoV-2 Molecular Testing Survey

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the preliminary results of its April 2020 SARS-CoV-2 Testing Survey for clinical laboratories. The anonymous survey was...
28-May-2020 8:00 AM EDT Add to Favorites

AMP Recommends Minimum Set of Pharmacogenetic Alleles to Help Standardize Clinical Genotyping Testing for Warfarin Response

AMP has published consensus, evidence-based recommendations to aid in the design, validation and interpretation of clinical genotyping tests for the prediction of warfarin response. The manuscript, “Recommendations for Clinical Warfarin...
5-May-2020 3:40 PM EDT Add to Favorites

AMP Expresses Support for Citizen Petition from the Coalition to Preserve Access to Pharmacogenomics Information

AMP has submitted a formal response in support of the Citizen Petition from Hyman, Phelps & McNamara, P.C. on behalf of the Coalition to Preserve Access to Pharmacogenomics (PGx) Information. The response builds on AMP’s PGx Best Practices...
4-May-2020 12:55 PM EDT Add to Favorites

Association for Molecular Pathology Commends Senator Rand Paul for Introducing the Verified Innovative Testing in American Laboratories (VITAL) Act of 2020

AMP applauds US Senator Rand Paul (R-KY) for introducing new legislation to allow molecular pathology professionals to continue advancing and offering laboratory developed testing procedures (LDPs) for patient care. The Verified Innovative Testing...
18-Mar-2020 9:50 AM EDT Add to Favorites

Association for Molecular Pathology Calls on Senate to Close Coverage Gaps for Clinical Laboratory Testing in Families First Coronavirus Response Act

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released a statement on H.R. 6201, the Families First Coronavirus Response Act, as passed by the House of Representatives on March...
16-Mar-2020 9:00 AM EDT Add to Favorites

Association for Molecular Pathology Announces 2019 Award Recipients

AMP has announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. These prestigious accolades will be presented this November during AMP’s 25th Annual...
19-Sep-2019 9:00 AM EDT Add to Favorites

AMP Recommends Clinical Pharmacogenomic Testing Best Practices to Preserve Broad Access and Improve Patient Care

AMP has published a new position statement for pharmacogenomic testing. Based on a recent assessment of the current market landscape, the statement includes a list of criteria for laboratories to follow for these types of tests to ensure responsible...
4-Sep-2019 9:45 AM EDT Add to Favorites

AMP Bolsters Position on Consumer Genomic Testing

AMP has revised its official position for all consumer genomic testing. Based on a recent assessment of the current market landscape and privacy best practices, the latest position statement features an expanded list of conditions that must be met...
10-Jun-2019 11:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,500+ members practice in the various disciplines of molecular diagnostics, including bioinformatics, infectious diseases, inherited conditions, and oncology. They include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees. Through the efforts of its Board of Directors, Committees, Working Groups, and members, AMP is the primary resource for expertise, education, and collaboration in one of the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing.

Contacts

Elisabeth Campbell
Communications Manager

ecampbell@amp.org

301-634-7400

Laurie Menser
Director of Strategic Development

lmenser@amp.org

301-634-7969

Mary Williams
Executive Director

mwilliams@amp.org

301-634-7921

Twitter

close
0.33904